No photo of Ingrid Stacey

Ingrid Stacey

Ms

  • The University of Western Australia (M431), 35 Stirling Highway,

    6009 Perth

    Australia

  • 698 Citations
  • 10 h-Index
20032016
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Ingrid Stacey is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Precursor Cell Lymphoblastic Leukemia-Lymphoma Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Pharmacokinetics Chemical Compounds
JNK Mitogen-Activated Protein Kinases Medicine & Life Sciences
Leukemia Medicine & Life Sciences
New South Wales Medicine & Life Sciences
Aurora Kinase A Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2016

  • 698 Citations
  • 10 h-Index
  • 15 Article
  • 1 Review article
9 Citations (Scopus)

Knowledge of the signs and symptoms and risk factors of lung cancer in Australia: mixed methods study

Crane, M., Scott, N., O'Hara, B. J., Aranda, S., Lafontaine, M., Stacey, I., Varlow, M. & Currow, D., 13 Jun 2016, In : BMC Public Health. 16, p. 508

Research output: Contribution to journal › Article

Open Access
Signs and Symptoms
Lung Neoplasms
Hemoptysis
Smoking
Focus Groups
14 Citations (Scopus)

Efficacy of CPX-351, (cytarabine: DAunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program

Carol, H., Fan, M. M. Y., Harasym, T. O., Boehm, I., Mayer, L. D., Houghton, P., Smith, M. A. & Lock, R. B., 1 Jan 2015, In : PEDIATRIC BLOOD & CANCER. 62, 1, p. 65-71 7 p.

Research output: Contribution to journal › Article

Daunorubicin
Cytarabine
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Heterografts
Liposomes
8 Citations (Scopus)

Unconditional and conditional incentives differentially improved general practitioners' participation in an online survey: randomized controlled trial

Young, J. M., O'Halloran, A., McAulay, C., Pirotta, M., Forsdike, K., Stacey, I. & Currow, D., Jun 2015, In : Journal of Clinical Epidemiology. 68, 6, p. 693-7 5 p.

Research output: Contribution to journal › Article

General Practitioners
Motivation
Randomized Controlled Trials
Surveys and Questionnaires
Costs and Cost Analysis
53 Citations (Scopus)

Association between tobacco plain packaging and Quitline calls: a population-based, interrupted time-series analysis

Young, J. M., Stacey, I., Dobbins, T. A., Dunlop, S., Dessaix, A. L. & Currow, D. C., 20 Jan 2014, In : The Medical journal of Australia. 200, 1, p. 29-32 4 p.

Research output: Contribution to journal › Article

Open Access
Product Packaging
Tobacco
Population
Tobacco Products
Health
42 Citations (Scopus)

Cell and molecular determinants of in vivo efficacy of the BH3 mimetic ABT-263 against pediatric acute lymphoblastic leukemia xenografts

Suryani, S., Carol, H., Chonghaile, T. N. I., Frismantas, V., Sarmah, C., High, L., Bornhauser, B., Cowley, M. J., Szymanska, B., Evans, K., Boehm, I., Tonna, E., Jones, L., Manesh, D. M. O., Kurmasheva, R. T., Billups, C., Kaplan, W., Letai, A., Bourquin, J. P., Houghton, P. J. & 2 othersSmith, M. A. & Lock, R. B., 1 Sep 2014, In : Clinical Cancer Reserach. 20, 17, p. 4520-4531 12 p.

Research output: Contribution to journal › Article

Open Access
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Heterografts
Pediatrics
Coculture Techniques
navitoclax